BsmI polymorphism of the vitamin D receptor gene in hyperparathyroid or hypoparathyroid dialysis patients

American Journal of Clinical Pathology

Volumn 112, Issue 3, 1999, Pages 366-370

  Tagliabue, Jacopo ^a   Farina, Marco ^b   Imbasciati, Enrico ^b   Vergani, Carlo ^a   Annoni, Giorgio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

End stage renal disease; Hyperparathyroidism; Hypoparathyroidism; Vitamin D receptor gene

Indexed keywords

ALKALINE PHOSPHATASE; PARATHYROID HORMONE; VITAMIN D RECEPTOR;

ADULT; AGE; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; DIALYSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HYPERPARATHYROIDISM; HYPOPARATHYROIDISM; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033491135     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/112.3.366     Document Type: Article

References (18)

1. Morrison NA, Yeoman R, Kelly PJ, et al. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A. 1992;89:6665-6669.
2. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284-287.
3. Garnero P, Borel O, Sornay-rendu E, et al. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women.J Bone Miner Res. 1995;10:1283-1288.
4. Peacock M. Vitamin D receptor gene alleles and osteoporosis: a contrasting view. J Bone Miner Res. 1995;10:1294-1297.
5. Lawrence Riggs B, Nguyen TV, Melton J, et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res. 1995;10:991-996.
6. Spector TD, Keen RW, Arden NK, et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ. 1995;310:1357-1360.
7. 3. Biochem J. 1996;316:361-371.
8. Darwish HM, DeLuca HE. Recent advances in the molecular biology of vitamin D action. Prog Nucleic Acid Res Mol Biol. 1996;53:321-344.
9. Drueke TB, Kubrusly M. Pathogenesis of secondary hyperparathyroidism of chronic renal failure. J Nephrol. 1994;7:139-147.
10. Sherrad DJ, Hercz G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure: an evolving disorder. Kidney Int. 1993;43:436-442.
11. Felsenfeld AJ, Rodriguez M, Dunlay R, et al. A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy. Nephrol Dial Transplant. 1991;6:244-251.
12. Hercz G, Pei Y, Greenwood C, et al. Aplastic osteodystrophy without aluminium: the role of "suppressed" parathyroid function. Kidney Int. 1993;44:860-866.
13. Lim SK, Park YS, Park JM, et al. Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans. J Clin Endocrinol Metab. 1995;80:3677-3681.
14. Carling T, Kindmark A, Hellman P, et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med. 1995;1:1309-1311.
15. Fernandez E, Fibla J, Betriu A, et al. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol. 1998;8:1546-1552.
16. Tsukamoto Y, Heishi M, Nagaba Y, et al. More on hyperparathyroidism and the vitamin D receptor [letter]. Nat Med. 1996;2:1162.
17. McCarey D, Spooner R, Jagger C, et al. The BSM-1 vitamin D receptor polymorphism and secondary hyperparathyroidism. Nephrol Dial Transplant. 1998;13:811-812.
18. Schmidt S, Chudek J, Karkoszka H, et al. The BsmI vitamin D-receptor polymorphism and secondary hyperpara-thyroidism. Nephrol Dial Transplant. 1997;12:1771-1772.